{"id":"omega-3-fatty-acid-ethylester90","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Fishy aftertaste"},{"rate":null,"effect":"Bleeding tendency"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL4298065","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Omega-3 fatty acids (EPA and DHA) work by activating peroxisome proliferator-activated receptors (PPARs) and G-protein coupled receptor 120 (GPR120), which enhance fatty acid oxidation in mitochondria and reduce the production of triglyceride-rich lipoproteins in the liver. This leads to decreased circulating triglyceride levels and improved lipid profiles, with potential anti-inflammatory and cardioprotective effects.","oneSentence":"Omega-3 fatty acid ethylester reduces triglycerides and modulates lipid metabolism by increasing fatty acid oxidation and reducing hepatic triglyceride synthesis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:50:36.218Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertriglyceridemia"},{"name":"Cardiovascular disease prevention"}]},"trialDetails":[{"nctId":"NCT01596842","phase":"PHASE4","title":"Effect of Omega-3 Fatty Acid on Vitamin D Activation","status":"COMPLETED","sponsor":"Dong-A University","startDate":"2012-05","conditions":"Hemodialysis Patients, Vitamin D Insufficiency, Vitamin D Deficiency","enrollment":17},{"nctId":"NCT00549692","phase":"PHASE3","title":"Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy","status":"COMPLETED","sponsor":"Kuhnil Pharmaceutical Co., Ltd.","startDate":"2007-11","conditions":"IgA Nephropathy","enrollment":152}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Omacor®"],"phase":"phase_3","status":"active","brandName":"Omega-3 fatty acid ethylester90","genericName":"Omega-3 fatty acid ethylester90","companyName":"Kuhnil Pharmaceutical Co., Ltd.","companyId":"kuhnil-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Omega-3 fatty acid ethylester reduces triglycerides and modulates lipid metabolism by increasing fatty acid oxidation and reducing hepatic triglyceride synthesis. Used for Hypertriglyceridemia, Cardiovascular disease prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}